Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...
Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...
Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibod...
Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...
Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irre...
Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...
Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...
Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...
Singapore: Biopharmaceutical company Nanotherapeutics has selected GE Healthcare Life Sciences' FlexFactory biomanufactu...
Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroi...
Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...
Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...
Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...
Singapore: Jubilant Biosys, a subsidiary of Bangalore-based Jubilant Life Sciences, has expanded its drug discovery alli...
Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myel...
